INTRODUCTION
The Rap proteins are members of the ras superfamily of lowmolecular-mass GTP-binding proteins. To date, four distinct proteins have been identified: RaplA, IB, 2A and 2B (Pizon et al., 1988a,b; Kitayama et al., 1989; Ohmstede et al., 1990; Lapetina et al., 1991) . All share approximately 50 % amino acid sequence identity with the ras proteins, with the degree of similarity within the Rap group being greater than 60 %. RaplA was initially identified by its ability to reverse the transformed phenotype of NIH 3T3 cells expressing the K-ras oncogene product (Kitayama et al., 1989) . RaplB is approximately 95% identical at the amino acid level to RaplA and, similarly, inhibits a ras-dependent pathway, i.e. meiotic maturation, in Xenopus oocytes . Work in vitro has led to speculation that the mode of action of RaplA in transformation reversal may involve binding to the ras GTPase-activating protein (GAP), thereby blocking ras action (Frech et al., 1990) .
Both Rap2A and Rap2B were identified by their similarity to ras. Using a Drosophila Dras3 probe, Pizon et al. (1988a) identified Rap2A from a human lymphoma cell line cDNA library. Rap2B was identified from a platelet cDNA expression library ) using a monoclonal antibody (M90) recognizing an epitope among amino acid residues 107-130 of H-ras (Lacal and Aaronson, 1986) . Although as yet no activity in vivo has been ascribed to the Rap2 proteins, the localization of Rap2 to the specific granules of neutrophils has been reported recently (Maridonneau-Parini and de Gunzburg, 1992) .
In this paper we show that the microinjection of recombinant Rap2A or Rap2B induces dramatic morphological changes in the pigmented animal hemisphere of Xenopus oocytes. These alterations, which we refer to as mottling, can also be triggered by microinjection of the RNA coding for Rap2B and can be blocked by co-injection with a microfilament stabilizing agent. The association of microinjected recombinant Rap2B with an oocyte membrane fraction suggests that the protein is modified by the oocyte. Preventing the processing of the recombinant fraction. Like other members of the ras superfamily, Rap2B possesses a C-terminal CAAX motif that serves as a signal for post-translational processing. Mutation of the cysteine residue in the CAAX motif to serine prevents the association of Rap2B with oocyte membranes, and also prevents mottling. This result suggests that post-translational processing of Rap2B is required for the observed effect. Mottling was blocked by boiling Rap2B prior to its microinjection or by co-injection of the cytoskeletal reagent phalloidin.
Rap2B by mutating the cysteine residue in the CAAX motif to serine blocks the association of Rap2B with oocyte membranes and also prevents mottling.
MATERIALS AND METHODS

Oocyte Isolation and microinjection
Adult female Xenopus laevis were obtained from Xenopus I (Ann Arbor, MI, U.S.A.) and individual oocytes were isolated as described previously (Campa and Kilberg, 1989) . Following an overnight incubation at 19°C in modified Barth's medium (Colman, 1984) , oocytes were microinjected with purified recombinant Rap2A or Rap2B protein or with in-vitro-transcribed RNA. The microinjection volume was held constant at 50 nl. Variations in the quantity of Rap2 protein microinjected were achieved by adjusting the protein content of the solutions prior to microinjection. Protein concentrations were estimated using a dye-binding assay (Pierce) with BSA as standard.
Quantffication of mottling
Following microinjection, oocytes were observed for signs of mottling using a Wild Leitz M5A binocular dissecting microscope at 15 x magnification. Oocytes were scored positive for mottling with the appearance of well-defined unpigmented spots located on the animal hemisphere, similar to those shown in Figure   1 (a), 4 h after microinjection. The appearance of the spots is characteristic of the Rap2 effect and was not observed after microinjection of other members of the ras superfamily of proteins (see the Results section for details). A total of 10-20 oocytes were used for each condition. 232 M. J. Campa and others et al., 1990) . The purity ofthe protein used for microinjection was estimated to be greater than 90 % by Coomassie Blue staining.
The Rap2A coding sequence was subcloned into a BamHI/EcoRI-digested pGEX-2T vector (Pharmacia) and the product was expressed as a fusion protein. Expression and purification ofthe glutathione S-transferase-Rap2A protein were as described in Ausubel et al. (1989) . Thrombin (1 %, w/w) was incubated with the purified fusion protein for 1 h at 25°C to liberate recombinant Rap2A.
A mutant Rap2B, in which the cysteine at position 180 is replaced by a serine, was generated using a standard PCR protocol following the manufacturer's directions with the oligonucleotide primers 5'-CCCGGGGGATCCATGAGAGAGTA-CAAAGTG-3' and 5'-CCCGGGGAATTCTTATCAGAGGA-TCACGGAGGC-3'. The PCR-generated fragment was gelpurified, digested with BamHI/EcoRI and subcloned into BamHI/EcoRI-digested pGEX-2T as described above. The purified protein was shown not to incorporate a prenyl moiety in vitro (results not shown).
In vitro transcripfton of Rap2B cDNA
The full-length cDNA of Rap2B isolated from a human platelet cDNA library was subcloned into the EcoRI site of pGEM-3Z. The orientation of the insert was established by sequencing and restriction digest analysis. Run-off transcripts were prepared by digesting the plasmid at the unique NarI site located 3' to the insert. The linearized plasmid was transcribed with SP6 polymerase according to the manufacturer's instructions (Promega). To confirm that the transcription product encoded Rap2B of the expected molecular mass, the RNA was translated in a methionine-deficient rabbit reticulocyte lysate system (Promega). A standard 50 ,1 reaction containing 2 jug of RNA and 4,1 of
[35S]methionine (1200 Ci/mmol; 10 mCi/ml) was incubated for 1 h at 30 'C. A 10 #1 aliquot ofthe reaction mixture was subjected to SDS/PAGE and the dried gel used to expose Kodak XAR film overnight. An anti-sense transcript was generated by digesting the vector at the HindlIl site located 5' to the insert and transcription was initiated by T7 polymerase.
Oocyte membrane Isolation
At various times after microinjection, an oocyte membrane fraction was prepared based on the procedure of Colman (1984) . Thirty oocytes were homogenized in 1 ml of ice-cold T-1 50 buffer (150 mM NaCl, 20 mM Tris/HCl, pH 7.6, 10 mM MgCl2, 10 ,ug of aprotinin/ml, 10 jug of leupeptin/ml, 1 mM phenylmethanesulphonyl fluoride) containing 10 % (w/v) sucrose. The homogenate was layered over a step gradient consisting of 1 ml of 20 % and 1 ml of 50 % (w/v) sucrose in T-50 buffer (same as T-150 buffer, except that it contains 50 mM NaCl). The tubes were centrifuged at 4 'C for 35 min at 15000 g in a TST 60.4 rotor (Sorvall). The 20 %/50 % sucrose interface was then transferred to a clean centrifuge tube, diluted several-fold with T-1 50 buffer and centrifuged at 4 'C for 60 min at 200000 g in a fixed-angle rotor. The resulting membrane pellet was solubilized in 200 ,l of 100 mM NaCl, 20 mM Tris/HCl, pH 7.6, 1 % (v/v) Triton X-100 and proteinase inhibitors and the extract was cleared by centrifugation at 12000 g in a microcentrifuge for 15 min at 4 'C.
Preparation of oocyte extracts
Total oocyte extracts were prepared by homogenizing oocytes in buffer containing 100 mM NaCl, 20 mM Tris/HCl, pH 7.6, 1 % (v/v) Triton X-100 and proteinase inhibitors. Oocytes were homogenized using 10 ,u of homogenization buffer per oocyte. The homogenates were cleared by centrifugation at 12000 g for 5 min at 4°C in a microcentrifuge and the supernatant fractions were stored at -80°C until use.
Immunoprecipitation
For immunoprecipitation of microinjected Rap2B, solubilized membrane proteins from 30 oocytes were diluted into 450 ,ul of RIPA buffer [150 mM NaCl, 50 mM Tris/HCl, pH 8.0, 1 % (v/v) Nonidet P-40, 0.5 % (w/v) sodium deoxycholate, 0.1 % (w/v) SDS, and proteinase inhibitors] and 6 4t1 of anti-Rap2 serum was added. After incubation for 60 min on ice, Protein A-Sepharose (CL4B; Pierce) was added and the incubation continued for an additional 45 min with rotation. The pellet was washed three times with RIPA buffer and once with 10 mM Tris/HCl, pH 7.5, and then boiled for 4 min in SDS/PAGE sample buffer. Electrophoresis was carried out as described below.
Electrophoresis and Western blotting
Proteins were separated via SDS/PAGE on a 12 % (w/v) polyacrylamide gel according to the method of Laemmli (1970) . The proteins in the gel were then electrophoretically transferred to nitrocellulose and the excess sites blocked by incubation for 30 min in buffer A [200 mM NaCl, 50 mM Tris/HCl, pH 7.6, 0.02 % (w/v) NaN3, 0.1 % (w/v) BSA, 0.1 % (w/v) poly(ethylene glycol) (approx. molecular mass 15-20 kDa)] containing an additional 3 % (w/v) BSA. The nitrocellulose was then incubated for 60 min at room temperature in primary antibody (anti-Rap2 serum) diluted in buffer A. The blot was washed three times for 5 min each in buffer A, and then diluted alkaline phosphataseconjugated secondary antibody was added. Following a 45 min incubation, the blot was washed as before and immunoreactive proteins visualized with Nitro Blue Tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate.
RESULTS
Mottiing in oocytes induced by microinjected recombinant Rap2 protein Recombinant Rap2B was purified from E. coli (Molina y Vedia et al., 1990) and microinjected into Xenopus oocytes. Approx. 4 h after microinjection, a distinctive rearrangement of the pigment granules of the animal hemisphere (hereafter referred to as mottling) was observed. The Rap2B-injected oocytes initially developed a series of small (30-40 um diameter) unpigmented spots on the surface of the animal hemisphere. These spots gradually increased in size and number over the next few hours until the entire hemisphere was mottled (Figure la) . The time course of mottling determined using oocytes from several different female frogs was remarkably consistent (Figure 2a ). More than 90 % of the oocytes showed signs of mottling within 10 h after microinjection. The relative potency of Rap2B for inducing mottling is illustrated in Figure 2( Figure. we sought to determine the fate of microinjected Rap2B with respect to its association with oocyte membranes. Oocytes were microinjected with 40 ng of Rap2B and monitored for signs of mottling. At various times after microinjection, oocytes were homogenized and a membrane fraction was isolated (Colman, 1984) . Following solubilization of the membranes, immunoprecipitation was performed using anti-Rap2 antiserum. As illustrated in Figure 4 , no Rap2B was detected in the oocyte membrane fraction immediately after microinjection. However, after 2 h, approx. 20 % of the oocytes showed signs of mottling and Rap2B was detected in the oocyte membranes. After 4 h, all of the oocytes had begun to mottle and the association of the microinjected protein with the membrane fraction had also increased. In agreement with data from other laboratories (Gutierrez et al., 1989) , the unprocessed recombinant protein migrated at a slightly higher molecular mass than the processed protein (Figure 4) . In order to better substantiate the notion that membrane attachment of microinjected Rap2B is indeed required for mottling, we generated a mutant Rap2B in which the cysteine residue of the CAAX box was changed to serine, as described in the Materials and methods section. Other laboratories have shown that this mutation prevents processing and subsequent membrane localization of the protein . Microinjection of the mutated protein into oocytes did not cause mottling, whereas the wild4type protein did. After the oocytes that had been microinjected with wild-type Rap2B had become mottled, total homogenate and membrane fractions from all oocytes were analysed by SDS/PAGE and immunoblotting for the presence of Rap2. As illustrated in Figure 5 , no Rap2B was detected in the control (GST-injected) oocytes in either the total extract or the membrane fraction (lanes 1 and 4) . However, both the wild-type Rap2B and the Cys-.Ser mutant were present in the extract (lanes 2 and 3) . In contrast, only the wild-type protein was associated with the oocyte membranes (lane 5). Moreover, the wild-type Rap2B migrated as a doublet in the total homogenate (lane 2), with the lower band, representing the processed species, migrating at the same molecular mass as the protein in the membrane fraction (lane 5).
Inhibition of mottling by phalloldin The microinjection of phalloidin, a toxic peptide from Amanita phalloides (Dancker et al., 1975) , into cultured cells results in marked alterations in the structure and organization of actin microfilaments (Wehland et al., 1977) . When microinjected at a concentration of 200 ,M, phalloidin caused the aggregation of actin polymers that were easily visible using immunofluorescence microscopy (Wehland et al., 1977) . At concentrations between 200 and 500,tM, the toxin decreased cell locomotion, and at 1 mM it resulted in a cessation of cell growth (Wehland et al., 1977) . In oocytes, phalloidin inhibited Rap2B-induced mottling in a dose-dependent manner (Figure 6 ). Total inhibition was observed with 500 ,uM phalloidin. Oocytes receiving the combination of Rap2B and 500 ,M phalloidin showed no signs of mottling, while those receiving Rap2B alone were heavily mottled. The appearance of the oocytes 8 h after Rap2B microinjection with or without phalloidin is shown in Figure l 
DISCUSSION
The results presented above demonstrate a characteristic rearrangement of the pigment granules in oocytes, termed mottling, following the microinjection of recombinant Rap2 proteins. Although both Rap2A and Rap2B caused mottling, the bulk of the experiments were performed using the Rap2B protein. As indicated by the altered mobility of microinjected Rap2B in SDS gels and its association with an oocyte membrane fraction, it is clear that the recombinant protein is processed by oocytes (Figures 4 and 5) . Moreover, C-terminal processing appears to be required for Rap2B to cause mottling, as a processing-defective mutant is unable to do so ( Figure 5) . A plausible explanation for mottling is that the microinjected Rap2B competes with endogenous CAAX-motif-containing proteins for processing, thereby inactivating proteins required for the maintenance of oocyte pigmentation. However, this possibility was ruled out by our finding that the C-terminal 20 amino acid residues of Rap2B or Rap2A were incapable of inducing mottling when microinjected into oocytes (results not shown) although being of sufficient length to serve as substrates for protein prenyltransferases (Reiss et al., 1990) .
A separate class of low-molecular-mass GTP-binding proteins with which morphological alterations have been associated is the rho family. The rho proteins are substrates for the C3 ADPribosyltransferase from Clostridium botulinum (Sekine et al., 1989) . Inactivation of endogenous rho in cultured cells by microinjected C3 causes disruption of actin filaments and gross morphological changes that are observable at the light microscope level (Paterson et al., 1990) . In experiments analogous to those in oocytes described above, Mohr et al. (1990) An interesting finding is that phalloidin, a toxin from Amanita phalloides, blocks Rap2B-induced mottling in oocytes ( Figures  Id and 6) . Phalloidin has been shown to stabilize existing microfilaments and to promote the polymerization of monomeric actin (Wieland, 1977; Wehland et al., 1977; Dancker and Hess, 1990) . Although the inhibition of mottling by phalloidin by no means proves that mottling is a result of a direct interaction of Rap2B with oocyte microfilaments, it does suggest that some component of the oocyte cytoskeleton is involved in the phenomenon. A plausible interpretation of the inhibitory effect of phalloidin is that mottling is a result of microfilament depolymerization. This, however, implies that any reagent leading to an increase in the proportion of monomeric actin should produce mottling. The cytochalasins, a family of toxic metabolites produced by certain species of moulds, cause microfilament depolymerization by preventing the addition of actin monomers to the ends of existing microfilaments (Lin et al., 1980) . In oocytes, although both cytochalasins B and D caused perturbations in the pigmented animal hemisphere in the absence of Rap2B, the effect was quite distinct from Rap2B-induced mottling (results not shown). Microinjection of Rap2B immediately preceding exposure to cytochalasin did not result in mottling per se, but magnified the effect of the toxin. In the light of this result, we believe mottling to be the result of a cytoskeletal restructuring that, by definition, involves a depolymerization/repolymerization sequence. Phalloidin prevents the initial depolymerization step while cytochalasin blocks the subsequent repolymerization. Once again, we stress that this notion does not necessarily imply a direct interaction of Rap2B with oocyte microfilaments, but simply that microfilament reorganization is likely to be involved in mottling.
Regardless of the mode of action by which the Rap2 proteins cause mottling in Xenopus oocytes, the results presented above represent the first report of a biological effect associated with this sub-class of low-molecular-mass GTP-binding proteins. The localization of Rap2 to the cytoplasmic face of the specific granules of human neutrophils was demonstrated recently (Maridonneau-Parini and de Gunzburg, 1992) and suggests a role for this family of proteins in the trafficking of vesicles in transit from cytoplasmic locations to the plasma membrane. Mottling may reflect an analogous function of Rap2 in oocytes, a cytoskeletal reorganization being required for vesicle movement. Attempts to detect endogenous Rap2 in oocytes have been unsuccessful, however, possibly indicating that Rap2 function in Xenopus may not be required until a later stage of development, with the effect on oocyte pigmentation resulting from the premature presence of Rap2.
